Jun 25, 2024

The New York Times published a hit piece against free market forces in health care, specifically attempting to undermine the value that pharmacy benefit managers (PBMs) provide every day to secure savings on egregiously high-priced prescription drugs.

The fact-less article indeed relies on sweeping generalizations, one-off anecdotes, and subjective terminology — rather than EMPIRICAL DATA. The article reads as if taken directly from Big Pharma’s talking points — designed to push government intrusion into the prescription drug market to further boost the profits of big drug companies, at the expense of everyone else.

Conservatives aren’t fooled and are seeing through The New York Times’ biased (again) reporting. On Friday, a groundswell of conservative voices promptly called out the article for its pro-pharma hatchet job — and highlighted several reasons it should come as no surprise — since the big corporate media, especially The Times, Big Pharma, and Big Government politicians have been allies in several endeavors, including trying to help Democrats defeat Republicans so they can advance their shared agenda.

See what they had to say:

Jack Posobiec, Senior Editor of Human Events, observed The Times article sounded like it was pulled directly from the pharmaceutical industry’s talking points:

Charlie Kirk, founder and executive director of Turning Point USA, noted Big Pharma has donated millions of dollars to elect Democrats to office, including Joe Biden, who in turn they expect to do their bidding by pushing for policies that boost drug company profits and undermine the free market in health care: 

Republican leaders and policy experts corrected the record on The Times article, explaining that PBMs provide critical value in the market and deliver significant savings for American businesses, taxpayers, and consumers:

Former Secretary of State Mike Pompeo:  

Joe Grogan, visiting senior fellow at the USC Schaeffer Center and former domestic policy adviser to former President Trump:

Former U.S. Senator Pat Toomey (R-PA):

Former U.S. Congressman Ryan Costello (R-PA):

This isn’t the first time The New York Times misreported and distorted the facts. Ashely Rindberg, journalist and author, published a book, “The Gray Lady Winked: How the New York Times’s Misreporting, Distortions and Fabrications Radically Alter History,” focused on the many instances where The Times’ misrepresentation of the truth has led to devastating consequences. 

Republicans in Congress should reject the Big Pharma-Big Government-Big Media agenda — and protect market forces and pharmacy benefits. The alternative would be increased costs for businesses, taxpayers, and consumers — less freedom for employers — and higher profits and more pricing power for Big Pharma.